Results 211 to 220 of about 13,407 (237)

Influencing factors analysis of clinical effect of heart failure patients treated with ivabradine and metoprolol succinate and construction and validation of nomogram prediction model. [PDF]

Front Cardiovasc Med
Wu G, Chen D, Chen L, Wu Y, Guan S, Wu F, Chen Y, Ye X, Yang T.   +8 more
europepmc   +1 more source

Long-term safety and efficacy of ivabradine after direct percutaneous coronary intervention in patients with acute myocardial infarction complicated by heart failure: a single-center retrospective study. [PDF]

BMC Cardiovasc Disord
Guo X, Yang W, Cui Y, Guo R, Zhu Y, Liu T, Chen K, Liu C.   +7 more
europepmc   +1 more source

A Prospective Clinical Audit to Improve Compliance With Perioperative Atrial Fibrillation Prevention Protocols in Off-Pump Coronary Artery Bypass Surgery. [PDF]

Cureus
Rahman MZ, Islam M, Sajidujjaman M, Chakroborty S, Hasan SR.   +4 more
europepmc   +1 more source

Pharmacological interventions to enhance exercise capacity in patients with heart failure. [PDF]

World J Cardiol
Naito R.
europepmc   +1 more source

Antianginal effectiveness and tolerability of ivabradine in patients with stable angina: CONTROL-2 Study results

, 1970
Karpov IuA, М. Г. Глезер, Yu. A. Vasyuk, R. T. Saygitov, E. L. Shkolnik   +4 more
openalex   +1 more source

Pediatric Heart Failure Pharmacotherapy: Transformative Insights for the Future. [PDF]

Rev Cardiovasc Med
Das BB.
europepmc   +1 more source

Myocardial Injury After Non-Cardiac Surgery in Otolaryngology: Evidence Gaps and a Systematic Review. [PDF]

J Clin Med
Domka J, Kasza R, Ziętek L, Smyła-Gruca W, Antkowiak M, Koniewska A, Gamrot-Wrzoł M, Kowalski D, Misiołek H, Misiołek M, Białka S.   +10 more
europepmc   +1 more source

Comparative cohort study of post-acute COVID-19 infection with a nested, randomized controlled trial of ivabradine for those with postural orthostatic tachycardia syndrome (the COVIVA study). [PDF]

Front Neurol
Saunders D, Arnold TB, Lavender JM, Bi D, Alcover K, Hellwig LD, Leazer ST, Mohammed R, Markos B, Perera K, Shaw D, Kobi P, Evans M, Mains A, Tanofsky-Kraff M, Goguet E, Mitre E, Pratt KP, Dalgard CL, Haigney MC.   +19 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Ivabradine

Reactions Weekly, 2022
Abstract The cells of the sinoatrial (SA) node generate a cyclical change in their resting membrane potential that drives them towards the threshold that triggers an action potential. The spontaneous depolarization current is a combined Na+/K+ inward current, termed the Ifunny current (I(f)).
openaire   +2 more sources

Ivabradine

2016
Ivabradine is a blocker of the funny current channels in the sinoatrial node cells. This results in pure heart rate reduction when elevated without direct effect on contractility or on the vessels. It was tested in a large outcome clinical trial in stable chronic heart failure (CHF) with low ejection fraction, in sinus rhythm, on a contemporary ...
openaire   +2 more sources